Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The quinoline derivatives quinine, its stereoisomer quinidine, and chloroquine may worsen or provoke disorders of neuromuscular transmission. In this study, we investigate effects of these drugs on neuromuscular transmission by conventional microelectrode as well as patch-clamp techniques. At 5 x 10-5 M, quinine, quinidine, and chloroquine reduced the quantal content of the end-plate potential by 37-45%. Between 10-6 and 10-4 M, all 3 drugs progressively decreased the amplitude and decay time constant of miniature end-plate potential (MEPP) and miniature end-plate current (MEPC); at 5 x 10-3 M, the MEPP became undetectable. The effect on the MEPP was not reversed by 1 μg/ml neostigmine. Single-channel patch-clamp analysis of the effects of quinine showed that this agent causes a long-lived open-channel as well as a closed-channel block of AChR. Tests for competitive inhibition or desensitization of the acetylcholine receptor (AChR) by quinine in concentrations that had a marked effect on the MEPC and on single-channel open and closed intervals were negative. Because quinoline drugs adversely affect both presynaptic and postsynaptic aspects of neuromuscular transmission at concentrations close to those employed in clinical practice, they should not be used, or used with caution, in disorders that compromise the safety margin of neuromuscular transmission.

Original languageEnglish (US)
Pages (from-to)179-189
Number of pages11
JournalBrain Research
Volume712
Issue number2
DOIs
StatePublished - Mar 18 1996

Fingerprint

Quinidine
Quinine
Miniature Postsynaptic Potentials
Chloroquine
Cholinergic Receptors
Neuromuscular Junction Diseases
Pharmaceutical Preparations
Neostigmine
Stereoisomerism
Excitatory Postsynaptic Potentials
Microelectrodes
Patch-Clamp Techniques
Safety
quinoline

Keywords

  • acetylcholine receptor
  • channel block
  • chloroquine
  • neuromuscular transmission
  • patch-clamp analysis
  • quinidine
  • quinine
  • transmitter release

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission. / Sieb, Jörn P.; Milone, Margherita; Engel, Andrew G.

In: Brain Research, Vol. 712, No. 2, 18.03.1996, p. 179-189.

Research output: Contribution to journalArticle

@article{24f3e1e9b80d4685b25bdc9bf71817d4,
title = "Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission",
abstract = "The quinoline derivatives quinine, its stereoisomer quinidine, and chloroquine may worsen or provoke disorders of neuromuscular transmission. In this study, we investigate effects of these drugs on neuromuscular transmission by conventional microelectrode as well as patch-clamp techniques. At 5 x 10-5 M, quinine, quinidine, and chloroquine reduced the quantal content of the end-plate potential by 37-45{\%}. Between 10-6 and 10-4 M, all 3 drugs progressively decreased the amplitude and decay time constant of miniature end-plate potential (MEPP) and miniature end-plate current (MEPC); at 5 x 10-3 M, the MEPP became undetectable. The effect on the MEPP was not reversed by 1 μg/ml neostigmine. Single-channel patch-clamp analysis of the effects of quinine showed that this agent causes a long-lived open-channel as well as a closed-channel block of AChR. Tests for competitive inhibition or desensitization of the acetylcholine receptor (AChR) by quinine in concentrations that had a marked effect on the MEPC and on single-channel open and closed intervals were negative. Because quinoline drugs adversely affect both presynaptic and postsynaptic aspects of neuromuscular transmission at concentrations close to those employed in clinical practice, they should not be used, or used with caution, in disorders that compromise the safety margin of neuromuscular transmission.",
keywords = "acetylcholine receptor, channel block, chloroquine, neuromuscular transmission, patch-clamp analysis, quinidine, quinine, transmitter release",
author = "Sieb, {J{\"o}rn P.} and Margherita Milone and Engel, {Andrew G}",
year = "1996",
month = "3",
day = "18",
doi = "10.1016/0006-8993(95)01349-0",
language = "English (US)",
volume = "712",
pages = "179--189",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission

AU - Sieb, Jörn P.

AU - Milone, Margherita

AU - Engel, Andrew G

PY - 1996/3/18

Y1 - 1996/3/18

N2 - The quinoline derivatives quinine, its stereoisomer quinidine, and chloroquine may worsen or provoke disorders of neuromuscular transmission. In this study, we investigate effects of these drugs on neuromuscular transmission by conventional microelectrode as well as patch-clamp techniques. At 5 x 10-5 M, quinine, quinidine, and chloroquine reduced the quantal content of the end-plate potential by 37-45%. Between 10-6 and 10-4 M, all 3 drugs progressively decreased the amplitude and decay time constant of miniature end-plate potential (MEPP) and miniature end-plate current (MEPC); at 5 x 10-3 M, the MEPP became undetectable. The effect on the MEPP was not reversed by 1 μg/ml neostigmine. Single-channel patch-clamp analysis of the effects of quinine showed that this agent causes a long-lived open-channel as well as a closed-channel block of AChR. Tests for competitive inhibition or desensitization of the acetylcholine receptor (AChR) by quinine in concentrations that had a marked effect on the MEPC and on single-channel open and closed intervals were negative. Because quinoline drugs adversely affect both presynaptic and postsynaptic aspects of neuromuscular transmission at concentrations close to those employed in clinical practice, they should not be used, or used with caution, in disorders that compromise the safety margin of neuromuscular transmission.

AB - The quinoline derivatives quinine, its stereoisomer quinidine, and chloroquine may worsen or provoke disorders of neuromuscular transmission. In this study, we investigate effects of these drugs on neuromuscular transmission by conventional microelectrode as well as patch-clamp techniques. At 5 x 10-5 M, quinine, quinidine, and chloroquine reduced the quantal content of the end-plate potential by 37-45%. Between 10-6 and 10-4 M, all 3 drugs progressively decreased the amplitude and decay time constant of miniature end-plate potential (MEPP) and miniature end-plate current (MEPC); at 5 x 10-3 M, the MEPP became undetectable. The effect on the MEPP was not reversed by 1 μg/ml neostigmine. Single-channel patch-clamp analysis of the effects of quinine showed that this agent causes a long-lived open-channel as well as a closed-channel block of AChR. Tests for competitive inhibition or desensitization of the acetylcholine receptor (AChR) by quinine in concentrations that had a marked effect on the MEPC and on single-channel open and closed intervals were negative. Because quinoline drugs adversely affect both presynaptic and postsynaptic aspects of neuromuscular transmission at concentrations close to those employed in clinical practice, they should not be used, or used with caution, in disorders that compromise the safety margin of neuromuscular transmission.

KW - acetylcholine receptor

KW - channel block

KW - chloroquine

KW - neuromuscular transmission

KW - patch-clamp analysis

KW - quinidine

KW - quinine

KW - transmitter release

UR - http://www.scopus.com/inward/record.url?scp=0029868615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029868615&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(95)01349-0

DO - 10.1016/0006-8993(95)01349-0

M3 - Article

C2 - 8814892

AN - SCOPUS:0029868615

VL - 712

SP - 179

EP - 189

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -